您当前的位置：
首页 >
文章列表页 >
Zhenzhu Tiaozhi Capsules Reduce Renal Lipid Deposition and Inflammation in Mouse Model of Diabetic Kidney Disease via SCAP-SREBP-1c/NLRP3 Signaling Pathway
更新时间：2025-05-30

    • Zhenzhu Tiaozhi Capsules Reduce Renal Lipid Deposition and Inflammation in Mouse Model of Diabetic Kidney Disease via SCAP-SREBP-1c/NLRP3 Signaling Pathway

    • “The latest research found that Zhenzhu Tiaozhi Capsule can significantly improve the renal damage in diabetes nephropathy mice, which may reduce the lipid deposition and inflammation of the kidney by inhibiting the activation of SCAP-SREBP-1c/NLRP3 signal pathway.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 13, Pages: 114-121(2025)

    • DOI：10.13422/j.cnki.syfjx.20242036    

      CLC： R289;R587.1;R692

    • Received：20 August 2024，

      Accepted：19 November 2024，

      Published Online：20 November 2024，

      Published：05 July 2025

    移动端阅览

  • ZHANG Tao,TAO Jie,ZHANG Yinghui,et al.Zhenzhu Tiaozhi Capsules Reduce Renal Lipid Deposition and Inflammation in Mouse Model of Diabetic Kidney Disease via SCAP-SREBP-1c/NLRP3 Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(13):114-121. DOI： 10.13422/j.cnki.syfjx.20242036.

  •  
  •  

0

Views

17

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Effect of Shenkang Injection on Podocyte Apoptosis and GRP78/CHOP Signaling Pathway in db/db Mice with Diabetic Kidney Disease Based on Endoplasmic Reticulum Stress
Shenqi Dihuang Decoction Improves Renal Function in Mouse Model of Diabetic Kidney Disease by Inhibiting Arachidonic Acid-related Ferroptosis Via ACSL4/LPCAT3/ALOX15 Axis
Mechanism of Modified Shengjiangsan in Improving Diabetic Kidney Disease by Activating Mitochondrial Autophagy Based on PINK1/Parkin Signaling Pathway
Multidimensional Analysis of Mechanisms of Nuciferine Against Cerebral Ischemia Based on Transcriptomic Data

Related Author

ZHANG Tao
TAO Jie
ZHANG Yinghui
YANG Yiqi
RONG Xianglu
GUO Jiao
CAI Yanmo
WANG Sitong

Related Institution

Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine， Guangdong Pharmaceutical University
School of Traditional Chinese Medicine， Beijing University of Chinese Medicine
Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences
The First Affiliated Hospital of Hunan University of Chinese Medicine
Graduate School， Hunan University of Chinese Medicine
0